COVID-19 in kidney transplant recipients

Am J Transplant. 2020 Jul;20(7):1941-1943. doi: 10.1111/ajt.15891. Epub 2020 Apr 12.
No abstract available

Keywords: clinical research/practice; colchicine; immunosuppressive regimens; infection and infectious agents - viral; infectious disease; kidney transplantation/nephrology.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Betacoronavirus
  • COVID-19
  • Cobicistat / administration & dosage
  • Colchicine / administration & dosage
  • Coronavirus Infections / complications*
  • Coronavirus Infections / therapy*
  • Cytokines / metabolism
  • Darunavir / administration & dosage
  • Drug Combinations
  • Female
  • Humans
  • Hydroxychloroquine / administration & dosage
  • Immunosuppressive Agents / administration & dosage
  • Kidney Failure, Chronic / complications*
  • Kidney Failure, Chronic / surgery
  • Kidney Transplantation*
  • Lopinavir / administration & dosage
  • Male
  • Middle Aged
  • Mycophenolic Acid / administration & dosage
  • Pandemics
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / therapy*
  • Ritonavir / administration & dosage
  • SARS-CoV-2
  • Tacrolimus / administration & dosage
  • Tacrolimus / blood
  • Transplant Recipients
  • Treatment Outcome

Substances

  • Cytokines
  • Drug Combinations
  • Immunosuppressive Agents
  • lopinavir-ritonavir drug combination
  • Lopinavir
  • Hydroxychloroquine
  • Mycophenolic Acid
  • Cobicistat
  • Ritonavir
  • Colchicine
  • Tacrolimus
  • Darunavir